Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/4293
Title: Molecular investigation on the efficacy of Luteolin as a potent therapeutic agent for experimentally induced Hepatocellular carcinoma in Wistar albino rats
Researcher: Balamurugan, K
Guide(s): Karthikeyan, J
Keywords: hepatocellular carcinoma
Chemical carcinogenesis
Luteolin
Wistar albino rats
Biochemistry
Upload Date: 17-Aug-2012
University: Prist University
Completed Date: November 2011
Abstract: Luteolin is an important flavonoid with a potential anticancer effect. Luteolin, usually occurs in its glycosylated form in celery, green pepper, perilla leaf, and camomile tea, etc., and much as an aglycone in perilla seeds. Recently, a potent anticancer effect of luteolin has been shown in several experiments in vitro. A great amount of data have indicated the therapeutic benefits of luteolin against cancer. However, it remains unclear whether these benefits are similar and equally effective in both the early and advanced stages of cancer or carcinogene is. In this study, the effects of luteolin in the advanced stages of hepatocarcinogenesis has been reported using N-nitrosodiethylamine (DEN)-induced hepatocellular carcinoma (HCC) in male Wistar rats. For this experiment, rats were categorised into four groups. The rats which developed HCC, i.e., 15-16 weeks after DEN administration (post-HCC) were treated with luteolin and compared to untreated HCC-bearing rats. The levels of cancer marker enzymes viz., and#1048878;-fetoprotein and CEA which are the known serum markers for HCC and other serum and liver marker enzymes were found to decrease upon luteolin treatment compared to untreated HCCbearing rats. Luteolin stabilizes and restores the antioxidant defense system viz., GSH, CAT, SOD, GPx and GST. These antioxidant enzymes protect cells from ROS damage in DENinduced HCC. Luteolin protects the activities of liver injury and tumor markers by decreasing MDA. The antioxidant potential was further confirmed by the non-enzymatic antioxidants such as Vitamin-C, Vitamin E, GSH and MDA levels. The DEN induced treated group showed significantly decreased levels of Vitamin-C, Vitamin-E, GSH and MDA. The non-enzymatic antioxidants in the DEN induced luteolin treated rats were found to be similar to that of control (normal) rats. These findings indicated that luteolin reduces the DEN induced increased ROS generation during hepatocarcinogenesis and promotes the enzymatic and non-enzymatic antioxidant defense system..
Pagination: 83p.
URI: http://hdl.handle.net/10603/4293
Appears in Departments:Department of Biochemistry

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File105.83 kBAdobe PDFView/Open
02_dedication.pdf3.93 MBAdobe PDFView/Open
03_declaration.pdf88.84 kBAdobe PDFView/Open
04_certificate.pdf88.61 kBAdobe PDFView/Open
05_abstract.pdf30.35 kBAdobe PDFView/Open
06_acknowledgement.pdf9.62 kBAdobe PDFView/Open
07_table of contents.pdf40.88 kBAdobe PDFView/Open
08_abbreviations.pdf20.34 kBAdobe PDFView/Open
09_list of figures.pdf5.18 kBAdobe PDFView/Open
10_list of tables.pdf6.35 kBAdobe PDFView/Open
11_list of publications.pdf3.37 kBAdobe PDFView/Open
12_chapter 1.pdf45.49 kBAdobe PDFView/Open
13_chapter 2.pdf211.79 kBAdobe PDFView/Open
14_chapter 3.pdf131.59 kBAdobe PDFView/Open
15_chapter 4.pdf193.7 kBAdobe PDFView/Open
16_chapter 5.pdf45.16 kBAdobe PDFView/Open
17_figures and tables.pdf3.87 MBAdobe PDFView/Open
18_publications.pdf1.66 MBAdobe PDFView/Open
19_reference.pdf168.3 kBAdobe PDFView/Open


Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.